Hawaii HB 966: RELATING TO ACCESS TO TREATMENT FOR TERMINALLY ILL PATIENTS.

Status: Reported from HLT (Stand. Com. Rep. No. 199-24) as amended in HD 1, recommending passage on Second Reading and referral to CPC. (as of 2024-02-08)

State: Hawaii · Session: 2024 · Bill: HB 966

Subjects: Biological Products, Investigational Drugs, Right-to-Try Act, Terminally Ill Patients

Sponsors: AMATO, BELATTI, GANADEN, GATES, HUSSEY-BURDICK, LAMOSAO, MARTEN, MATAYOSHI, MIZUNO, NAKASHIMA, NISHIMOTO, PERRUSO, TAKENOUCHI, TARNAS, TODD, Poepoe

View Hawaii HB 966 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.